Atypical Imaging in Autoimmune Pancreatitis Lessens Accuracy in MDCT
Multi detector computed tomography for autoimmune pancreatitis may not provide fully accurate diagnosis if abnormalities are detected.
Atypical imaging features in autoimmune pancreatitis can diminish the diagnostic accuracy of multiple detector computed tomography (MDCT) in differentiating autoimmune pancreatitis, pancreatic ductal adenocarcinoma, and acute interstitial pancreatitis, according to a study published in the American Journal of Roentgenology.
Researchers from the David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center and the UCLA School of Public Health in Los Angeles, CA, and Yale School of Medicine in New Haven, CT, sought to identify the most common imaging features of autoimmune pancreatitis and to evaluate the utility of MDCT for differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma and acute interstitial pancreatitis.
The researchers evaluated MDCT images from 39 patients with autoimmune pancreatitis, 25 with pancreatic ductal adenocarcinoma, and 27 with acute interstitial pancreatitis. They were looking for distribution of pancreatic abnormality, sausage shape, low-attenuation halo, pancreatic duct dilatation, peripancreatic stranding, lymphadenopathy, biliary abnormality, vascular involvement, and renal lesions.
The results showed that sausage shape and low-attenuation halo were the most common imaging features found in autoimmune pancreatitis (25 [64%] and 23 [59%], respectively), while pancreatic duct dilatation and biliary dilatation were most frequent in pancreatic ductal adenocarcinoma (20 [80%] and 11 [44%], respectively). In interstitial pancreatitis, the most frequent finding was peripancreatic stranding (22 [81%]).
“Sausage shape, low-attenuation halo, and absence of a pancreatic duct or biliary dilatation differentiated autoimmune pancreatitis from pancreatic ductal adenocarcinoma with an accuracy of 0.88,” the authors wrote. “Sausage shape and absence of peripancreatic stranding differentiated autoimmune pancreatitis from acute interstitial pancreatitis with an accuracy of 0.82. There was no significant difference in the frequency of vascular involvement or of lymphadenopathy among these diagnoses.”
The researchers concluded that there should be a high index of suspicion for autoimmune pancreatitis should there be pancreatic abnormalities on imaging. Further diagnostic workup could be suggested by radiologists, including correlation with serum immunoglobulin 4 level and tissue sampling, to potentially prevent unnecessary surgery.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
